Annals of the Rheumatic Diseases 2017 5.Pdf
Downloaded from http://ard.bmj.com/ on April 20, 2017 - Published by group.bmj.com Contents Volume 76 Issue 5 | ARD May 2017 ARDThe Eular Journal May 2017 Volume 76 Issue 5 76 Impact Factor 5 Editorial Clinical and epidemiological research 12.384 Volume 76 Volume Issue 5 779–934 Pages 779 Lesinurad combination therapy with allopurinol 811 Lesinurad in combination with allopurinol: a in gout: do CLEAR studies make the treatment randomised, double-blind, placebo-controlled study of gout clearer? in patients with gout with inadequate response to AnnAls of RheuMAtIc DIseAses of RheuMAtIc AnnAls J A Singh standard of care (the multinational CLEAR 2 study) T Bardin, R T Keenan, P P Khanna, J Kopicko, Criteria M Fung, N Bhakta, S Adler, C Storgard, 782 2016 American College of Rheumatology/ S Baumgartner, A So May 2017 May European League Against Rheumatism Criteria for 821 Development of the autoinflammatory disease Minimal, Moderate, and Major Clinical Response damage index (ADDI) in Juvenile Dermatomyositis: An International N M ter Haar, K V Annink, S M Al-Mayouf, Myositis Assessment and Clinical Studies Group/ G Amaryan, J Anton, K S Barron, S M Benseler, Editor Paediatric Rheumatology International Trials P A Brogan, L Cantarini, M Cattalini, A-V Cochino, Tore K Kvien Organisation Collaborative Initiative F De Benedetti, F Dedeoglu, A A De Jesus, Associate Editors L G Rider, R Aggarwal, A Pistorio, N Bayat, B Erman, O Della Casa Alberighi, E Demirkaya, P Dolezalova, Francis Berenbaum B M Feldman, A M Huber, R Cimaz, R J Cuttica, K L Durrant,
[Show full text]